<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28479">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01989416</url>
  </required_header>
  <id_info>
    <org_study_id>567-2556-EC4</org_study_id>
    <nct_id>NCT01989416</nct_id>
  </id_info>
  <brief_title>Effectiveness of Chlorhexidine Wipe for Prevention of Multidrug-resistant Organisms in Intensive Care Unit Patients</brief_title>
  <official_title>Effectiveness of Chlorhexidine Wipe for Prevention of Multidrug-resistant Organisms in Intensive Care Unit Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <authority>Thailand: Ethical Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine 2% chlorhexidine wipes are effective in preventing
      of colonization of multi-drug resistant bacteria in intensive care unit patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the usefulness of bathing with chlorhexidine wipe
      to reduce the risks of multidrug resistant bacteria acquisition and hospital-acquired
      bloodstream infection among ICU patients
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>The overall rate of Multidrug resistant bacteria acquisition at 7 days after received 2% chlorhexidine  wipe bathing versus  with soap bathing</measure>
    <time_frame>7 days after recieved 2% chlorhexidine wipes</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>7 days after received 2% chlorhexidine wipes,the microbiology laboratory will process surveillance specimens using either standard culture-based at both nostrils, axillar, groins, rectum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The overall rate of hospital-acquired bloodstream infections  per 1000 patient-days with chlorhexidine wipe bathing versus  with soap bathing</measure>
    <time_frame>48 hours after recieved 2% chlorhexidine wipes</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">472</enrollment>
  <condition>Antibiotic Resistant Infection</condition>
  <arm_group>
    <arm_group_label>Soap bathing</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>ICU patients will be bathing with soap at least once daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2% chlorhexidine wipes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use 2% chlorhexidine wipes to clean the patient at least once daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% chlorhexidine wipe</intervention_name>
    <description>The ICU patients will be bathing with 2% chlorhexidine wipe</description>
    <arm_group_label>2% chlorhexidine wipes</arm_group_label>
    <other_name>chlorhexidine wipe</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Admission in critical care unit eg. ICU, respiratory care unit, Cardiac care unit
             with in 24 hours

          -  Expected duration of critical care unit admission &gt; 48 hours

        Exclusion Criteria:

          -  History of chlorhexidine allergy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adhiratha Boonyasiri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adhiratha Boonyasiri, MD</last_name>
    <phone>+6685-063-2181</phone>
    <email>adhiratha.bon@mahidol.ac.th</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adhiratha Boonyasiri, MD</last_name>
      <phone>+6685-063-2181</phone>
      <email>adhiratha.bon@mahidol.ac.th</email>
    </contact>
    <investigator>
      <last_name>Adhiratha Boonyasiri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 14, 2013</lastchanged_date>
  <firstreceived_date>October 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Adhiratha Boonyasiri</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>colonization</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
